Q3 2024 EPS Estimates for Green Thumb Industries Inc. (OTC:GTBIF) rose by analyst

Green Thumb Industries Inc. (OTC:GTBIF – Free Report) – Analysts at Alliance Global Partners boosted their Q3 2024 earnings estimates for Green Thumb Industries in a research note issued to investors on Tuesday, August 6th. Alliance Global Partners analyst A. Gray now anticipates that the company will post earnings of $0.06 per share for the quarter, up from their prior estimate of $0.04. Alliance Global Partners also issued estimates for Green Thumb Industries’ Q4 2024 earnings at $0.06 EPS, FY2024 earnings at $0.34 EPS, Q1 2025 earnings at $0.06 EPS, Q2 earnings at $0.06 EPS. 2025 at $0.06 EPS, Q3 2020 earnings $0.07 EPS and FY2025 earnings at $0.25 EPS.

Separately, Ventum Cap Mkts raised shares of Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday.

Read our latest research report on GTBIF

Green Thumb Industries price performance

Shares of GTBIF stock opened at $11.25 on Friday. Green Thumb Industries has a 1 year low of $6.42 and a 1 year high of $16.33.

About Green Thumb Industries

(Get a free report)

Green Thumb Industries Inc manufactures, distributes, markets and sells medical and adult cannabis products in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals and other cannabis-related products under the brands &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, Incredibles and RHYTHM.

See Also

Get daily news and reviews for Green Thumb Industries – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Green Thumb Industries and related companies with MarketBeat.com’s FREE daily email newsletter.